Clinical Presentations

LINC 2025

“Randomized Controlled Trial of a First-Generation Carotid Stent versusMicroNet-Covered Stent: 3-Year outcomes” Savr Bugurov, Centre of Vascular and Hybrid Surgery, E.N.Meshalk in National Medical Research Center of the Ministry of Health

LINC 2025

"Proximal Embolic Protection a must-know-how for competent carotid stenting” Piotr Musialek, Jagiellonian University Dept. of Cardiac & Vascular Diseases, John Paul II Hospital, Kraków, Poland

VEITH 2024

MicroNet-Covered Anti-Embolic Stent in Consecutive Increased-Risk Iliac Artery Stenotic Lesions to Reconstruct Anatomy and Guard The Flow: A Multi-Center, Multi-Specialty Study FLOWGUARD-ILIAC NCT04461717

TCT 2024

“Multi-Center Study of the MicroNET-Covered Stent in Consecutive Patients with Acute Carotid-Related Stroke: SAFEGUARD-STROKE”

TCT 2024

“Where Does Interventional Cardiologist Fit in Advancing Interventional Treatment of Stroke?” Piotr Musialek, Jagiellonian University Dept. of Cardiac & Vascular Diseases St. John Paul II Hospital, Krakow, Poland

VEITH 2024

Can Mesh Covered Stents Replace Stent-Grafts For The Treatment Of Complex Iliac Occlusive Lesions: Advantages And Disadvantages Piotr Myrcha, I Chair and Clinic of General and Vascular Surgery,Faculty of Medicine, Medical University of Warsaw, Head of Department of General, Vascular and Oncological Surgery, Mazovian BrodnowskiHospital, Warsaw,Poland

VEITH 2024

“Update On All Trial Results With CGuard And CGuard Prime MicroMesh Covered Stents (InspireMD): Are They Making A Difference And Limitations With Transfemoral/Transradial CAS: Evidence Summary And Long-Term Outcomes” Piotr Musialek, Jagiellonian University Dept. of Cardiac & Vascular Diseases St. John Paul II Hospital, Krakow, Poland

VILNIUS VASCULAR SYMPOSIUM

Carotid Anti-Embolic (’Mesh’) Stent: Optimal Endovascular Therapy Piotr Musialek Jagiellonian University Dept. of Cardiac & Vascular Diseases John Paul II Hospital, Kraków, Poland

LINNC 2024

LINNC 2024 Tandem Lesions: How I manage these cases and European experience with the CGuard CAS system Dr. Adnan H. Siddiqui MD Phd, Chief Executive Officer & CMO Jacobs Institute

Carotid artery stenting with flow inversion cerebral protection and Micronet covered stent

T. Castrucci, A. Sciarra, A. Siani, F. Accrocca, G. Ianni, R. Cancellieri, R. Gandini, S. Vona, A. Borlizzi, S. Bartoli

CGuard Micronet™ mesh covered stent in asymptomatic carotidstenosis: a vascular center experience

Forcella E, Mastrorilli D, Miccoli T, Pruner G, Bedetti M, Garriboli L

CGuard™ short-term safety and long-term efficacy from a single-center prospective registry

GianbattistaParlani, Romano Lydia, Giacomo Isernia, Del MastroFrancesco Pio, Gioele Simonte Vascular & Endovascular Surgery S Maria Misericordia Hospital, Perugia, Italy

The dual-layer CGuardstent is safe and effective in emergent carotid artery stenting and in tandem occlusions: a multi-centric study

Dr. med Mousa Zidan Prof. Dr. Franziska Dorn Department of Neurology, Bonn University Hospital, Germany

Tommaso Castrucci UOC ChirurgiaVascolare OspedaleSant‘Eugenio-Roma

Adnan H. Siddiqui, MD PhD Chief Executive Officer & Chief Medical Officer, Jacobs Institute UB Distinguished Professor & Vice Chair, Department of Neurosurgery Director, Canon Stroke & Vascular Research Center SUNY University at Buffalo Director, Neurosurgical Stroke Service Kaleida Health

CAS with flow reversal cerebral protection and CGuardstent-brachial access-

Tommaso Castrucci UOC ChirurgiaVascolare OspedaleSant‘Eugenio-Roma

Carotid Revascularization 2024: Key Factors to Consider

LINC 2024

1 year Outcomes of the C- GUARDIANS Pivotal IDE Trial of the C-GUARD MicroNet Stent Chris Metzger, MD On Behalf of the C-GUARDIANS Investigators

CX International Symposium 2024

Optical Coherence Tomography analysis of CAS and the benefits of micromesh stent design Gianmarco de Donato Full Professor of Vascular Surgery Chief, Vascular Surgery Unit & Vascular Surgery Residency Program University of Siena, Italy

CX International Symposium 2024

Anti-embolic stent CAS vs single-layer stent CAS vs CEA Piotr Musialek, MD DPhil Jagiellonian University Dept. of Cardiac & Vascular Diseases, John Paul II Hospital, Kraków, Poland

ICI Meeting 2024

2nd Generation (Anti Embolic Stent) CAS vs. CEA, Prof. Piotr Musialek

CGuard Symposium at PVI 2023

CAS Today: Increased Relevance & Access Strategies

TCT 2023

Cracow Vascular Summit 2024

The MicroNet™ Covered Stent: What is NEW in 2023/2024 Prof. Piotr Musialek

VIVA 2023

30-Day Results of the C-GUARDIANS Pivotal Trial of the C-Guard Carotid Stent System The C-GUARDIANS Trial D. Christopher Metzger, MD, OhioHealth Riverside Methodist Hospital, Columbus, Ohio, USA on On Behalf of the C-GUARDIANS Investigators

TCT 2023

Staying Safe: Review of Protection in CAS | Prof. Piotr Musialek

LINC 2023

Acute Stroke of CArotid Artery Bifurcation Origin Treated With Use oF the MicronEtcovered CGUARD Stent (SAFEGUARD-STROKE, NCT05195658)

LINC 2023

Feasibility, Safety, and Efficacyof MicroNet-covered stent in consecutive increased-risk iliac stenoticlesions to reconstructanatomyand guard effective flow: A multi-center, multi-specialty studyFLOWGUARD-ILIAC, NCT04461717 - PiotrPaluszekon behalf of FLOWGUARD-ILIAC Investigators, Dept. of VascularSurgeryand Endovascular Interventions John Paul II Hospital, Krakow

LINC 2023

OCT Analysis of CAS Cases –The Benefits of MicroNet™ - Gianmarco de Donato Full Professor of Vascular Surgery, University of Siena-Italy

PCR 2023

CAS: State-of-the-Art – Piotr Musialek, MD DPhil Jagiellonian University Dept. of Cardiac & Vascular Diseases, John Paul II Hospital, Kraków, Poland

VEITH 2022

Results From A Multicenter Italian Study Of The C-Guard Micromesh Stent For CAS: Advantages And Complications | Francesco Speziale, MD

VEITH 2022

The 3 Micromesh Stents and Their Value In CAS: Do the Design Differences Matter? & Update On Carotid And Other Uses of the MicroNet™-Covered Stent (C-Guard) | Dr. Piotr Musialek and Dr. Max Amor

VEITH 2022

The C-GUARDIANS IDE Trial for the CGuard MicroNet™ Stent, and Context from Longer term European Data | Chris Metzger, MD

TCT 2022

Carotid Artery Endovascular Reconstruction Using MicroNet™-Covered Stents in Patients with Symptoms or Signs of Cerebral Ischemia – Piotr Musialek, MD DPhil for CGuard OPTIMA Investigations

LINC 2022

Randomized Controlled Trial of a First-Generation Carotid Stent versus MicroNet™-Covered Stent: 12-month outcomes - Savr Bugurov, MD

LINC 2022

Stent properties and vessel adaptability: Could these factors influence procedural outcomes? – Matteo Stefanini, MD

LINC 2022

MicroNet™-covered stent in stroke prevention and treatment: New evidence – Piotr Musialek, MD

VEITH 2021

New Multicenter Data Showing the Long-Term Value of the C-Guard MicroNet™ Covered Stent for High Risk Lesions (Thrombotic, Calcified and Symptomatic): From the Flow-Guard and Other Trials Drs. Piotr Musialek, Christopher Metzger

TCT 2021

Carotid artery revascularization using second generation stents versus surgery: A meta-analysis of clinical outcomes Dr. A. Mazurek, et al.

TCT 2021

Cardiology Cathlab-Based Management of Thrombotic Carotid Stenoses in Acute Ischaemic Stroke en Route to a Full Interventional Stroke Service - Tools, Techniques, Local Stroke Unit Collaboration: Challenges and Patient Outcomes Prof. Piotr Musialek, et al.

ESC 2021

One-Year Results from a Prospective Experience on CAS Using the Cguard Stent System: THE IRONGUARD -2 STUDY Pasqualino Sirignano, MD on behalf of the IRONGUARD2 study Group

LINC 2021

CGuard MicroNet™ – covered Stent in Primary and Secondary Stroke Prevention. Piotr Musiałek, MD

LINC 2021

“The safety and effectiveness of carotid revascularization with the Acculink stent and the CGuard stent. Independent randomized study”. Drs. Savr Bugurov, Andrey Karpenko, Pavel Ignatenko

LINC 2021

Carotid artery revascularization: A systematic review and meta-analysis comparing clinical outcomes of second vs. first generations stents. Adam Mazurek MD, PHD on behalf of CARMEN Collaborators

LINC 2021

12 months results from a prospective real-world multicenter clinical practice of CAS using the CGuard EPS: the IRONGUARD 2 study. Pasqualino Sirignano, MD

SVS ONLINE 2020

Results from a prospective real-world multicentre clinical practice of CAS using the CGuard embolic prevention system: the IRONGUARD 2 study – Pasqualino Sirignano, MD

ESC 2020

“ESC Essential Update 2020 Carotid Disease “- Piotr Musiałek, MD DPh FESC Jagiellonian University Department of Cardiac & Vascular Disease

PCR eCourse 2020

The SIBERIA trial for carotid artery stenosis: A randomized controlled trial of conventional versus MicroNet™-covered stent use in percutaneous neuroprotected carotid artery revascularization: Peri-procedural and 30-day diffusion-weighted magnetic resonance imaging and clinical outcomes Andrey Karpenko, Pavel Ignatenko et al.

LINC 2020

“OPTIMAl endovascular sequestration of high-risk carotid plaque using the CGuard™ MicroNet™–covered embolic prevention stent system in consecutive patients with sym--ptoms or signs of carotid stenosis-related brain injury: An intravascular ultrasound – controlled investigator-initiated multcentric multi-specialty study - CGuard™ OPTIMA” Prof. Piotr. Musialek

LINC 2020

Accumulating long‑term evidence for MicroNet™‑covered stent safety, efficacy and durability in primary and secondary stroke prevention: 5-year data from the PARADIGM-Extend prospective academic trial Prof. Piotr Musialek, et al

LINC 2020

“Immediate and one-month results from a prospective real-world multicentre clinical practice of CAS using the CGuard embolic prevention system: the IRONGUARD 2 study”. Dr. Pasqualino Sirignano, Prof Francesco Speziale

VEITH Symposium 2019

Update On The CGuard™ MicroNet™ Covered Stent For CAS: Longer-Term Results: Advantages And Are There Late Downsides Like ISR Or Late Thrombosis? Prof. Piotr Musialek

VEITH Symposium 2019

Preliminary Results From A Prospective Real - World Multicenter Clinical Practice Of CAS Using The CGuard EPS: The IRONGUARD 2 Study

SIVEC 2019

New data in carotid disease: CGuard MicroNet™-Covered Embolic Prevention Stent - State of the Art, Prof. Piotr Musiałek

TCT 2019

MicroNet™-Covered Self-EXpandableSTentIn High-RiskVascular Lesions Beyond The CArotidBifurcation: The EXTRA-GUARD Multi-centerMulti-specialty Study. Prof. Piotr Musialek

CIRSE 2019

Initial Clinical Study of the New CGuard™ MicroNet™ ® covered Carotid Stent: “One Size Fits All” In vitro testing and initial Clinical Results Christian Wissgott MD

PARADIGM-Extend Prospective Academic Trial

Supported K/ZDS/007819 (Jagiellonian University Medical College) Accumulating long-term evidence for MicroNet™-covered stent safety and stroke prevention efficacy Prof. Piotr Musiałek

ESC Congress 2019 Essential Update

Carotid Disease 2019 Prof. Piotr Musiałek

Initial Clinical Study of the New CGuard™ MicroNet™® covered Carotid Stent:

“One Size Fits All” In-vitro testing and initial Clinical Results Christian Wissgott MD

The SIBERIA Trial – CGuard™ MicroNet™® Covered Stent vs. AcculInk™

Basal, 30d DW-MRI and 1y Clinical Evaluation in 100 RandomIzed pAtients,” Per-Protocol Interim Results in a Randomized DW-MRI Controlled Study of Carotid Artery Revascularization using a MicroNet™ Mesh Stent Drs. Karpenko A, Ignatenko P

PARADIGM-EXTEND Prospective Academic Trial Of CGuard™ MicroNet™-Covered Self-Expandable Stent System

Cumulative 3-Year Clinical And Duplex Ultrasound Evidence For Safety, Efficacy And Durability Of Stroke Prevention Prof. Piotr Musialek

“Results of a Multicenter Italian Registry of Real World CAS with the C-Guard Mesh Covered Stent: the IRONGUARD 2 Study”

Prof. Francesco Speziale, Dr. Wassim Mansour

VEITHsymposium 2018

Results of a multicenter italian registry of real world CAS with the C-Guard mesh covered stent: the IRONGUARD 2 Study Drs. Francesco Speziale, Laura Capoccia

VEITHsymposium 2018

2 0 1 8 Update On Results With The CGuard™ MicroNet™ Covered Stent (InspireMD) For CAS: Does It Prevent Strokes: Does It Cause ISR Or Other Long-Term Problems: Can It Have Value In Other Vascular Beds? Piotr Musialek, MD DPhil

VEITHsymposium 2018

Clinical results and mechanical properties of a novel double-layered carotid stent (CGUARD) Christian Wissgott MD

Current Status of Carotid Interventions

Role of CAS in 2018

Carotid Angioplasty Evolution – 2018

Accumulating two-year clinical and duplex ultrasound evidence from the CGuard PARADIGM- Extend prospective academic trial: Durability of stroke prevention

TCT 2016

Twelve-month Safety and Efficacy of CGuard™ MicroNet™–covered Embolic Prevention Stent Routine Use to Perform Carotid Revascularization: TCT 2016 Featured Research PARADIGM All-Comer Prospective Academic Study

CIRSE 2016

CGuard™ EPS System – My experience in treatment of carotid lesions: Mechanical behavior and clinical results PD Dr. Christian Wissgott

Webcast Recording

Webcast Recording: Late Breaking Presentation from EuroPCR '16 CGuard and PARADIGM 101 with Prof. Musialek

EuroPCR 2016

CGuard Late Breaking Trial Presentation at EuroPCR: Novel PARADIGM in carotid revascularization by Dr. Musialek

LINC 2016

Carotid artery revascularization using CGuard™ MicroNet™-Covered Embolic Prevention Stent System: A Change in the Game

VEITHsymposium 2015

MicroNet™ Covered Embolic Prevention Carotid Stent System: From CARENET and PARADIGM Studies to Routine Clinical Practice

EuroPCR 2015

Endovascular management of highly calcified carotid lesions presented at EuroPCR 2015 by Dr. Adam Mazurek

EuroPCR 2015

The PARADIGM Study presented at EuroPCR 2015 by Dr. Piotr Musialek

EuroPCR 2015

CARENET update presented at EuroPCR 2015 by Dr. Joachim Schofer

LINC 2015

CARENET trial 6 month update presented at LINC 2015 by Dr. Piotr Musialek

ICI 2014

Comparison of the MGuard EPS with Standard Stents in AMI presented at ICI 2014 by Dr. Gregg Stone

TCT 2014

Presentation of 30 day CARENET results at TCT 2014 by Dr. Joachim Schofer

EuroPCR 2013

The Embolic Protection Stent - Beyond current techniques: a more effective solution in STEMI primary PCI at EuroPCR 2013 with J. Fajadet and J. Henriques

TCT 2013

MGuard™ Embolic Protection Stent: A More Effective Solution in STEMI Treatment at TCT 2013 with Dr. Gregg Stone

EuroPCR 2014

MGuard™ Embolic Protection Stent: The Importance of Thrombus Management in STEMI Primary PCI at EuroPCR 2014 with J. Fajadet and A. Abizaid

EuroPCR 2012

Challenging MGuard™ Cases by Dr. Praveen Chandra at EuroPCR 2012

EuroPCR 2012

Leon, Dudek, Silber, Lotan and Chandra at EuroPCR 2012

EuroPCR 2012

Follow-Up of the MAGICAL Trial by Dariusz Dudek at EuroPCR 2012

EuroPCR 2012

The MASTER RCT Design by Alexandre Abizaid at EuroPCR 2012